Liver Injury Due to Drugs and Viruses: Mechanistic Similarities and Implications for AAV Gene Therapy.

Abstract

Clinical Pharmacology & TherapeuticsEarly View Commentary Liver Injury Due to Drugs and Viruses: Mechanistic Similarities and Implications for AAV Gene Therapy Paul B. Watkins, Corresponding Author Paul B. Watkins pwatkins@email.unc.edu Institute for Drug Safety Sciences, University of North Carolina – Chapel Hill, Chapel Hill, North Carolina, USA Correspondence: Paul B. Watkins (pwatkins@email.unc.edu)Search for more papers by this author Paul B. Watkins, Corresponding Author Paul B. Watkins pwatkins@email.unc.edu Institute for Drug Safety Sciences, University of North Carolina – Chapel Hill, Chapel Hill, North Carolina, USA Correspondence: Paul B. Watkins (pwatkins@email.unc.edu)Search for more papers by this author First published: 15 December 2021 https://doi.org/10.1002/cpt.2500Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Early ViewOnline Version of Record before inclusion in an issue RelatedInformation